COVID-19 - Iceland - 23-01-12

Data from JHU, ca. 9:00 CET

Iceland is included in the following groups: Female Heads of State - Northern Europe - Europe - UNR Western European and Others Group - WHO European Region

absolutecases per 100.000 abs. development
1 day
rel. development
1 day
rel. development
7 days/average
Total infections 208459 57269.0 0 0.0% 0.01%
Active cases 485 133.2 0 0.0% 7.1%
Deaths 229 62.9 0 0.0% 0.0%
Recovered 20774557072.800.0%0.0%
1st Vaccinations 00.0%
Incidence 44.2
R7-Value 0.5
D7-Incidence 0.0
Deaths per infected 0.11%
Recovered per infected 99.66%
Deaths per recovered 0.11%
1st Vaccinations in Pop0.0%

A ranking may taste a bit fishy, as this is not a competition between countries, but to compare the relative efficiency of measures taken, or for detecting which countries are likely to get critical next, this ranking imho deserves a place in this overview.
Ranking within 200 evaluated states:
Population 176 Incidence: 40
D7 Incidence:101 R7 Value 115
Total casesCases per 100.000Average grow rate (7 days)
Infected 112 10 76
Active 96 37 25
Deaths 159 106 113
Recovered 112 9 136
The ranking is made over all groups and countries, including small or recent that are ommitted in the table on the front page - which may lead to minor discrepancies between both!

Gives the time necessary to double the existing infections - to reach a million from the existing status, or to reach the population limit of the given group (which can well be below a million). This assumes the exponential growrate over the last seven days continues - which it does not, as there will be saturation towards the maximum. Please take these calulations with two grains of salt. As long as there is turning point in sight the data may well hold, though.
Last weeks rate
Time to double active cases 10d 2h
Time to double total cases stable
Time to reach a million cases stable
Time to saturate the populationstable

Diagrams

Iceland in its groups

Female Heads of State - Northern Europe - Europe - UNR Western European and Others Group - WHO European Region